Head to head
Medtronic vs Abbott Laboratories
Side-by-side on the measures that matter, with a plain-English read. Full detail: MDT · ABT
MDT
Medtronic
99.94-0.67%
1-year price shape — +3% over the period
Quant Rating C · 42/100
vs
ABT
Abbott Laboratories
103.00-0.84%
1-year price shape — -15% over the period
Quant Rating D · 22/100
1-year performance, rebased to 100
Medtronic edges it on the scoreable measures. Medtronic has the highest Quant Rating (42); Medtronic has done best over the past year (+3%); Medtronic trades cheapest on trailing earnings.
| MDT | ABT | |
|---|---|---|
| Snapshot | ||
| Sector | Medical Devices | Medical Devices |
| Last price | 99.94 | 103.00 |
| Change today | -0.67% | -0.84% |
| 1-year return | +3.1% | -15.4% |
| Market cap | $127.84B | $178.39B |
| 52-week range | 72.06 – 106.20 | 80.89 – 126.70 |
| Valuation | ||
| P/E (TTM) | 24.62 | 38.29 |
| P/E percentile, own 5-yr range | 33rd | 99th |
| P/B | 2.54 | 3.50 |
| Dividend yield | 2.85% | 2.41% |
| Profitability & growth | ||
| EPS (TTM) | 3.73 | 3.72 |
| Net profit (TTM) | $4.77B | $6.44B |
| Revenue (TTM) | $37.54B | $48.23B |
| Provider revenue period date | 2026-07-30 | 2026-09-29 |
| Revenue growth (YoY) | +13.7% | +14.5% |
| Gross margin | 65.0% | 56.9% |
| Operating margin | 19.0% | 13.8% |
| Net margin | 13.9% | 9.7% |
| Free cash flow (TTM) | $6.13B | $6.76B |
| Provider cash-flow period date | 2026-07-30 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 95.7% | 81.2% |
| Insider activity (12mo) | 27 buy / 18 sell | 36 buy / 12 sell |
| Short interest (% of float) | 1.8% | 1.1% |
| Analyst consensus | 60% buy / 40% hold (20) | 93% buy / 7% hold (15) |
| Analyst price target | $107 (+7%) | $122 (+18%) |
| StockVane view | ||
| StockVane Quant Rating | C (42) | D (22) |
| Company | ||
| Employees | 95,000 | 115,000 |
| Founded | 1949 | 1900 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.